A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
暂无分享，去创建一个
S. Ely | K. van Besien | R. Pearse | U. Gergis | M. Coleman | Peter A Forsberg | T. Mark | R. Niesvizky | A. Rossi | D. Sherbenou | T. Shore | S. Mayer | A. Perry | J. Greenberg | Danielle Guarneri | D. Jayabalan | K. Pekle | June Greenberg | Linda Tegnestam